Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
11.8M
-
Number of holders
-
40
-
Total 13F shares, excl. options
-
5.12M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$143M
-
Value change
-
+$33.7M
-
Number of buys
-
23
-
Number of sells
-
-11
-
Price
-
$27.99
Significant Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) as of Q1 2025
47 filings reported holding PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q1 2025.
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.12M shares
of 11.8M outstanding shares and own 43.33% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (714K shares), BVF INC/IL (697K shares), Frazier Life Sciences Management, L.P. (690K shares), SAMSARA BIOCAPITAL, LLC (679K shares), ADAMS STREET PARTNERS LLC (410K shares), MILLENNIUM MANAGEMENT LLC (270K shares), Nantahala Capital Management, LLC (250K shares), Woodline Partners LP (194K shares), Opaleye Management Inc. (172K shares), and Blue Owl Capital Holdings LP (140K shares).
This table shows the top 40 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.